...
机译:利妥昔单抗治疗ANCA阴性韦格纳肉芽肿患者难治性球后肉芽肿:病例报告
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Division of Rheumatology and Allergy Department of Internal Medicine St. Marianna University School of Medicine 2-16-1 Sugao Kawasaki 216-8511 Japan;
Rituximab; Wegener’s granulomatosis; Retrobulbar granuloma; PR3 ANCA-negative;
机译:利妥昔单抗治疗ANCA阴性韦格纳肉芽肿患者难治性球后肉芽肿:病例报告。
机译:利妥昔单抗成功治疗ANCA阴性韦格纳肉芽肿。
机译:利妥昔单抗成功治疗ANCA阴性韦格纳肉芽肿
机译:用Rituximab在高级初级耐火或渐进非霍奇金淋巴瘤(NHL)中的rituximab的自同毒性方法。第二次报告
机译:免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性:RU051417I-R-ICE(利妥昔单抗-异环磷酰胺-卡铂-依托泊苷)与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤(DLBCL)。
机译:利妥昔单抗成功治疗ANCA阴性韦格纳肉芽肿
机译:用Rituctory Wegener的肉芽肿病毒治疗Rituximab的成功治疗,具有肥厚性嗜肥嗜肥疗养炎和右侧轨道粒状